Dr. Longe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10212 Lantern Rd
Fishers, IN 46037Phone+1 317-841-5656Fax+1 317-841-5751
Education & Training
- Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
- Woodhull Medical and Mental Health CenterResidency, Internal Medicine, 1993 - 1996
- University of Ilorin Faculty of Health SciencesClass of 1988
Certifications & Licensure
- IN State Medical License 2009 - 2025
- MA State Medical License 1996 - 2011
- AR State Medical License 1999 - 2000
- MI State Medical License 1996 - 1997
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- 36 citationsTelomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: Mechanism and therapeutic potential†Harold O. Longe, Paul B. Romesser, Andrew M. Rankin, Douglas V. Faller, Mark S. Eller
International Journal of Cancer. 2009-01-15 - T cell large granular lymphocytic leukemia, a rare form of post lung transplant lymphoproliferative disorderOmer Saeed, Harold O. Longe, Jiehao Zhou
Annals of Hematology. 2018-01-08 - Tumor Genomic Profiling to Determine Tissue Origin of Cancers of Unknown Primary: A Single Institute Experience With its Utility and Impact on Patient Management.Omer A M Saeed, Ayşe Armutlu, Liang Cheng, Harold O Longe, Romil Saxena
Applied Immunohistochemistry & Molecular Morphology. 2022-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: